Halozyme Therapeutics, Inc

Senior Director, Treasury

Halozyme Therapeutics, Inc$250K — $290K *
Finance & Insurance
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree with 12+ years of diverse financial experience
  • MBA preferred
  • 6+ years in corporate Treasury leadership roles
  • Experience with convertible debt portfolio management
  • Proven leadership in share repurchase programs for public companies
  • Consultation experience on M&A transactions
  • Global treasury experience is preferred

Responsibilities

  • Build a comprehensive treasury strategy aligned with corporate objectives
  • Provide treasury insights for Board and Investor communications
  • Partner with CFO on capital allocation and management
  • Forecast cash flows, royalties, and M&A outflows
  • Oversee treasury operations including bank admin and reconciliations
  • Evaluate and implement Treasury Management Systems
  • Manage investment portfolios ensuring liquidity and safety

Benefits

  • Full and comprehensive benefits package including stock purchase program and 401(k) matching
  • Opportunities for professional development through in-house programs
  • Collaborative and innovative team environment focused on impact
Full Job Description
Save time and apply through your LinkedIn account. Click the Apply with LinkedIn button and your LinkedIn profile will be imported into our site.

In order to move forward, you will need to create an account. Your password must be eight characters long, contain at least one special character, one capital letter and a number.

We look forward to discovering your talents.

How you will make an impact

The Senior Directory, Treasury is responsible for building and advancing a rapidly scalable cash generation strategy, convertible debt portfolio, and share repurchase program to meet the objectives of a high-growth, royalty driven biotechnology business. The Senior Director, Treasury will partner with the Chief Financial Officer on liquidity, capital allocation, risk management, and operational excellence through building scalable processes, controls, and capabilities.

In this role, you'll have the opportunity to:
  • Building a comprehensive treasury strategy aligned with Halozyme corporate objectives
  • Providing treasury perspective and modeling for Board and Investor communications on liquidity position, capital structure, risk management, and capital return strategy
  • Partnering with the Chief Financial Officer on developing and managing Halozyme's capital allocation strategy and decisions
  • Forecasting cash, royalties & milestone collections, payment timing, capital, share repurchases, and M&A outflows
  • Overseeing bank administration, signatory controls, online banking, and reconciliation processes
  • Evaluating and implementing Treasury Management Systems as needed
  • Developing, implementing, monitoring, and updating the short-term investment policies for cash reserves and marketable securities, balancing safety, liquidity, yield, and risk
  • Managing the investment portfolio, ensuring alignment with overall liquidity needs and debt obligations
  • Identifying, measuring, monitoring, and mitigating key financial risks including foreign exchange, interest rate risk, and credit risk
  • Recommending hedging strategies
  • Supporting broader enterprise risk management efforts that may intersect with treasury
  • Providing recommendations and execution on the share buyback plan
  • Analyzing debt capacity and determining optimal debt financing options
  • Modeling organic and M&A valuations, tracking, funding analysis, integration planning, and overall support for M&A, licensing deals, and business development opportunities
  • Establishing, documenting, and implementing continuous improvement measures for treasury policies, procedures, and SOX control (cash, banking, payments, risk management)
  • Ensuring compliance with debt covenants, SEC reporting requirements, and other regulatory obligations
  • Delivering timely reporting to the Chief Financial Officer, executive team, Audit Committee, and other stakeholders as required
  • Other duties as assigned


To succeed in this role, you'll need:
  • Bachelor's degree with at least 12 years of diverse financial and business experience
  • MBA preferred
  • At least 6 years of corporate Treasury leadership experience
  • Diverse experience in cross-disciplinary financial roles such as controllership, FP&A, tax, program finance, financial reporting, etc.
  • An equivalent combination of experience and education may be considered
  • Experience with managing various convertible debt portfolios
  • Experience leading share repurchase programs for public companies
  • Experience providing Treasury and/or financial consultation on M&A transactions
  • Experience leading cash flow efficiency and effectiveness initiatives
  • Experience consulting on hedging initiatives
  • Global treasury experience is preferred


In return, we offer you:
  • Full and comprehensive benefit program, including an Employee Stock Purchase Program and 401(k) matching.
  • Opportunities to grow in a culture that prioritizes learning, development and progression through in-house programs and tuition reimbursement.
  • A collaborative, innovative team that works as one to amplify your impact-on your career, the work you do and patients' lives.


The most likely base pay range for this position is $250K - $290K per year. Several factors, such as experience, tenure, skills, and particular business needs, will determine an individual's exact level of compensation. Base salary is only one element of employee compensation at Halozyme. Total compensation could include bonuses, sales incentives, and equity awards.

To view all our open positions, please visit our career page. Additionally, our benefit offerings can be found here.

About Halozyme Therapeutics, Inc

Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. The company's proprietary enzyme rHuPH20 is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs and improving patient convenience and compliance. Halozyme's lead investigational drug candidate, PEGPH20, is a PEGylated recombinant human hyaluronidase under clinical development for the treatment of pancreatic cancer and other solid tumors. The company was founded in 1998 and is headquartered in San Diego, California.
Learn more about Halozyme Therapeutics, Inc
Size
145 employees
Market Cap
$7.7 billion
Industry
Net Income
$129 million
Founded
1998
5 Year Trend
+24.8%
Revenue
$267.5 million
NASDAQ

Similar Jobs

More Jobs at Halozyme Therapeutics, Inc

More Finance & Insurance Jobs

Find similar Senior Director, Treasury jobs: